ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · IEX Real-Time Price · USD
10.98
-0.21 (-1.88%)
At close: Jul 26, 2024, 4:00 PM
10.95
-0.03 (-0.27%)
After-hours: Jul 26, 2024, 5:46 PM EDT
ARS Pharmaceuticals Revenue
ARS Pharmaceuticals had revenue of $10.00K in the twelve months ending March 31, 2024, down -98.51% year-over-year. In the year 2023, ARS Pharmaceuticals had annual revenue of $30.00K, down -97.72%.
Revenue (ttm)
$10.00K
Revenue Growth
-98.51%
P/S Ratio
106,391.04
Revenue / Employee
$385
Employees
26
Market Cap
1.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 30.00K | -1.29M | -97.72% |
Dec 31, 2022 | 1.32M | -4.19M | -76.10% |
Dec 31, 2021 | 5.51M | -12.33M | -69.13% |
Dec 31, 2020 | 17.84M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSPRY News
- 3 hours ago - ARS Pharmaceuticals Inc Investigated By The Schall Law Firm And Impacted Investors Urged To Engage In Dialogue - Accesswire
- 1 day ago - ARS Pharmaceuticals Inc Investigated By The Schall Law Firm And Impacted Investors Urged To Engage In Dialogue - Accesswire
- 1 day ago - ARS Pharmaceuticals Inc Investigated By The Schall Law Firm And Impacted Investors Urged To Engage In Dialogue - Accesswire
- 4 days ago - ARS Pharmaceuticals Inc Is Under Investigation By The Schall Law Firm And Impacted Investors Are Encouraged To Initiate Dialogue - Accesswire
- 7 days ago - ARS Pharmaceuticals Inc Is Under Investigation By The Schall Law Firm And Impacted Investors Are Encouraged To Initiate Dialogues - Accesswire
- 8 days ago - The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc And Urges Affected Investors To Start Conversations - Accesswire
- 9 days ago - ARS Pharmaceuticals Inc Is Under Examination By The Schall Law Firm, Impacted Investors Are Encouraged To Initiate Dialogues - Accesswire
- 10 days ago - The Schall Law Firm Urges Affected Investors To Start Conversation, ARS Pharmaceuticals Inc Is Under Scrutiny - Accesswire